Cancer News and Research

Latest Cancer News and Research

Encouraging data from Seattle Genetics' phase I trial of brentuximab vedotin

Encouraging data from Seattle Genetics' phase I trial of brentuximab vedotin

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

New study reveals RNA may play a critical role in cancer treatment

New study reveals RNA may play a critical role in cancer treatment

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Preclinical and Phase I data for TG-0054 presented by TaiGen Biotechnology

Early antisocial behaviours and parental factors affect various health outcomes 40 years later

Early antisocial behaviours and parental factors affect various health outcomes 40 years later

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Dabigatran etexilate prevents recurrent VTE with less bleeding than warfarin

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Positive clinical data from Phase II study of elacytarabine in patients with AML reported

Positive clinical data from Phase II study of elacytarabine in patients with AML reported

SU2C awards $9.68 million to support high-risk cancer research

SU2C awards $9.68 million to support high-risk cancer research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Updated results from phase III EXTEND clinical trial of pixantrone released

Updated results from phase III EXTEND clinical trial of pixantrone released

ChemGenex Pharmaceuticals presents clinical results of Omapro drug at ASH meeting

ChemGenex Pharmaceuticals presents clinical results of Omapro drug at ASH meeting

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

New three-drug combination may be effective for treating patients with bone cancer

New three-drug combination may be effective for treating patients with bone cancer

Salon Leau hosts hair service event to support childhood cancer research

Salon Leau hosts hair service event to support childhood cancer research

VAI expands to support annual research operation

VAI expands to support annual research operation

Albert Einstein College of Medicine receives SU2C grant for cancer research

Albert Einstein College of Medicine receives SU2C grant for cancer research

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

Poster summarizing clinical trial data regarding SB-743921 presented by Cytokinetics

Researchers explore optimal induction therapies for managing blood cancer

Researchers explore optimal induction therapies for managing blood cancer

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.